Mayne Pharma Group Ltd (MYX) — Cash Flow Reinvestment Rate
Mayne Pharma Group Ltd (MYX) has a Cash Flow Reinvestment Rate of 0.17x as of June 2025, reinvesting AU$5.40 Million (capex AU$5.40 Million ) from operating cash flow of AU$31.98 Million. See MYX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Mayne Pharma Group Ltd Cash Flow Reinvestment Rate (2010–2025)
Historical reinvestment intensity for Mayne Pharma Group Ltd across 12 annual periods. For the full cash flow conversion analysis, see MYX cash flow metrics.
Annual Cash Flow Reinvestment Rate for Mayne Pharma Group Ltd (2010–2025)
Year-by-year capital reinvestment analysis for Mayne Pharma Group Ltd. See MYX financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.70x | AU$12.28 Million | AU$17.47 Million | AU$12.28 Million | ▼ -55.3% |
| 2021 | 1.57x | AU$74.34 Million | AU$47.26 Million | AU$25.10 Million | ▲ +52.4% |
| 2020 | 1.03x | AU$102.99 Million | AU$99.78 Million | AU$47.12 Million | ▲ +6.2% |
| 2019 | 0.97x | AU$103.60 Million | AU$106.61 Million | AU$11.91 Million | ▼ -31.6% |
| 2018 | 1.42x | AU$172.53 Million | AU$121.50 Million | AU$54.18 Million | ▼ -33.0% |
| 2016 | 2.12x | AU$113.39 Million | AU$53.50 Million | AU$29.59 Million | ▲ +1038.3% |
| 2015 | 0.19x | AU$4.17 Million | AU$22.42 Million | AU$4.17 Million | ▲ +15.8% |
| 2014 | 0.16x | AU$4.20 Million | AU$26.14 Million | AU$4.20 Million | ▼ -94.8% |
| 2013 | 3.08x | AU$21.06 Million | AU$6.84 Million | AU$21.06 Million | ▲ +1517.0% |
| 2012 | 0.19x | AU$2.55 Million | AU$13.39 Million | AU$2.55 Million | ▼ -63.1% |
| 2011 | 0.51x | AU$2.10 Million | AU$4.09 Million | AU$2.10 Million | ▲ +1225.0% |
| 2010 | 0.04x | AU$398.56K | AU$10.26 Million | AU$398.56K | — |